-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TWw11UggmhS9EkABbxapV+cmFtIG3qpH14wuLmOSucN1WVFDW6HEmSNn6O2D2RAU dccv7LLBaB9yqrUkoGTV6g== 0001080171-10-000008.txt : 20100216 0001080171-10-000008.hdr.sgml : 20100215 20100216160650 ACCESSION NUMBER: 0001080171-10-000008 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100216 DATE AS OF CHANGE: 20100216 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ATHEROGENICS INC CENTRAL INDEX KEY: 0001107601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582108232 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60563 FILM NUMBER: 10607676 BUSINESS ADDRESS: STREET 1: 8995 WESTSIDE PARKWAY CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: 6783362500 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ARISTEIA CAPITAL LLC CENTRAL INDEX KEY: 0001080171 IRS NUMBER: 133953132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 136 MADISON AVE STREET 2: 3RD FL CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-842-8900 MAIL ADDRESS: STREET 1: 136 MADISON AVE STREET 2: 3RD FL CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: ARISTEIA ADVISORS LLC DATE OF NAME CHANGE: 19990226 SC 13G/A 1 agix13gasubmission.htm AGIX13GSUBMISSION UNITED STATES

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

                                                                                                                       

 

SCHEDULE 13G

Amendment No.1

 

Under the Securities Exchange Act of 1934

 

 

 

 

 

Atherogenics Inc.

 

(Name of Issuer)

 

Common Stock, no par value

(Title of Class of Securities)

 

 

 

047439104

 

 

 

 

(CUSIP Number)

 

 

12/31/09

(Date of Event Which Requires Filing of this Statement)

 

 

 

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[X]       Rule 13d-1(b)

            Rule 13d-1(c)

Rule 13d-1(d)

 

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No.047439104

 

SCHEDULE 13G

 

Page  2  of 5 Pages

 

 

1

 

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

Aristeia Capital, L.L.C. (1)

 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a)   [x]

(b)   [  ]

 

 

3

 

SEC USE ONLY

 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

 SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

5

 

SOLE VOTING POWER

 

0

 

6

 

SHARED VOTING POWER

 

0

 

7

 

SOLE DISPOSITIVE POWER

 

0

 

8

 

SHARED DISPOSITIVE POWER

 

0

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0

 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*                                              [ ]

 

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0

 

12

 

TYPE OF REPORTING PERSON*

 

IA

 

(1)     The shares or other interests described herein are held by one or more of Aristeia Master, L.P., Aristeia International Limited and Aristeia Partners, L.P. (the “Funds”).  Aristeia Capital, L.L.C. (the “Reporting Person”) is the investment manager of the Funds and has voting and investment control with respect to the shares or other interests held by the Funds.  Although each of the Reporting Person and certain of its affiliates may be deemed the beneficial owner of the shares held by the Funds pursuant to Rule 13d-3 under the Act, none owns such shares directly.  Each of the Reporting Person and such affiliates disclaims beneficial ownership of the shares held by the Funds except to the extent of their respective economic interests in each Fund.   

 

 

 

 

 

 

 

 

CUSIP No. 047439104

 

SCHEDULE 13G

 

Page   3  of   5  Pages

 

Item 1(a).        Name of Issuer:

 

Atherogenics Inc.

 

Item 1(b).        Address of Issuer's Principal Executive Offices:

                           

8995 Westside Parkway

Alpharetta, GA 30004

                                                 

Item 2(a).        Name of Person Filing.

Item 2(b).        Address of Principal Business Office or, if None, Residence.

Item 2(c).        Citizenship.

 

Aristeia Capital, L.L.C.

136 Madison Avenue, 3rd Floor

New York, NY  10016

Delaware limited liability company

 

Item 2(d).        Title of Class of Securities:

 

                        Common Stock, no par value

 

Item 2(e).        CUSIP Number:

 

                        047439104

 

Item 3.            If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

[ X ]     An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E).

 

Item 4.            Ownership.   

 

The following is information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1 as of 12/31/09:

 

            (a)        Amount beneficially owned:  0

 

(b)        Percent of Class:  0

 

(c)        Number of shares as to which such person has:

 

                        (i)         sole power to vote or direct the vote:  0

 

                        (ii)        shared power to vote or direct the vote:  0

 

 

 

 

 

 

CUSIP No.  047439104

 

SCHEDULE 13G

 

Page   4  of   5  Pages

 

                                    (iii)       sole power to dispose or direct the disposition of:  0

                                   

                                    (iv)       shared power to dispose or d  irect the disposition of:  0

 

Item 5.            Ownership of Five Percent or Less of a Class.

                       

                    [ X ]

Item 6.            Ownership of More than Five Percent on Behalf of Another Person.

                       

                        Not Applicable                       

 

Item 7.            Identification and Classification of the Subsidiary Which Acquired the Security

                        Being Reported on By the Parent Holding Company.

                       

            Not Applicable

 

Item 8.            Identification and Classification of Members of the Group.

                       

            Not Applicable

 

Item 9.            Notice of Dissolution of Group.

                       

            Not Applicable

 

Item 10.          Certification.

                       

                        Certification pursuant to §240.13d-1(b):

 

                        By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.    

 

 

 

 

 

CUSIP No. 047439104

 

SCHEDULE 13G

 

Page   5  of   5  Pages

 

 

SIGNATURE

 

            After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

           

            Dated: 02/16/10

                       

 

ARISTEIA CAPITAL, L.L.C.

 

 

By:  /s/ Robert H. Lynch, Jr.             

                                                                                                 Name: Robert H. Lynch, Jr.

                                                                                                 Title: Managing Member

          

 

 

 

 

 

 

 

-----END PRIVACY-ENHANCED MESSAGE-----